Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002083033-25-000001
Filing Date
2025-08-26
Accepted
2025-08-26 14:31:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5779
  Complete submission text file 0002083033-25-000001.txt   7879
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Subject) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42213 | Film No.: 251256060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O UNIT 03, 31/F, TOWER 2 LIPPO CENTRE NO. 89 QUEENSWAY, ADMIRALTY HONG KONG Hong Kong 00000
Business Address C/O UNIT 03, 31/F, TOWER 2 LIPPO CENTRE NO. 89 QUEENSWAY, ADMIRALTY HONG KONG Hong Kong 00000 85234622091
Soul Ventures Holdings Ltd (Filed by) CIK: 0002083033 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SCHEDULE 13G